News & Updates
Filter by Specialty:

Use of 6MWD predicts survival in fibrosing non-IPF ILD
17 May 2024
Patients with fibrosis nonidiopathic pulmonary fibrosis (non-IPF) interstitial lung disease (ILD) who show longitudinal declines in 6-min walk distance (6MWD) appear to have increased mortality, suggest the results of a recent study.
Use of 6MWD predicts survival in fibrosing non-IPF ILD
17 May 2024
Many female lung cancer patients left out by screening criteria: study
16 May 2024
byStephen Padilla
The National Lung Screening Trial (NLST) in Singapore falls short of identifying some individuals, particularly women, who are at an increased risk of developing lung cancer, according to a study. However, those who meet the criteria may derive significant benefits from the screening.